Gainers

• Innovative Eyewear (NASDAQ:LUCY) stock moved upwards by 95.4% to $1.49 during Monday's regular session. The market value of their outstanding shares is at $4.8 million.
• Seer (NASDAQ:SEER) shares rose 37.66% to $2.23. The company's market cap stands at $89.0 million.
• Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock increased by 33.37% to $0.12.
• YD Bio (NASDAQ:YDES) stock rose 27.63% to $2.42. The market value of their outstanding shares is at $134.5 million.
• Axe Compute (NASDAQ:AGPU) stock moved upwards by 20.5% to $8.53. The market value of their outstanding shares is at $76.5 million.
• Celularity (NASDAQ:CELU) shares rose 19.95% to $0.74. The market value of their outstanding shares is at $17.6 million.

Losers

• SL Science Holding (NASDAQ:SLBT) stock decreased by 23.2% to $4.6 during Monday's regular session. The market value of their outstanding shares is at $3.3 billion.
• Basel Medical Group (NASDAQ:BMGL) stock declined by 14.62% to $7.13. The market value of their outstanding shares is at $13.0 million.
• BioXcel Therapeutics (NASDAQ:BTAI) stock declined by 14.5% to $1.18. The company's market cap stands at $42.6 million.
• Aktis Oncology (NASDAQ:AKTS) shares fell 13.84% to $27.36. The market value of their outstanding shares is at $1.7 billion.
• Universe Pharmaceuticals (NASDAQ:UPC) shares declined by 12.5% to $5.53. The company's market cap stands at $4.0 million.
• TransCode Therapeutics (NASDAQ:RNAZ) stock decreased by 12.32% to $7.55. The company's market cap stands at $8.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.